Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
RGENthis companyRepligen Corporation	$176.40	188.34×	4.38×	12.48×	51.17×	-83.4%	47.1%	8.1%	6.6%	2.3%	1.6%	1.0%	0.33×	0.68×	2.57×	8.37×	0.0%	4	9.05	1	C-
AAgilent Technologies, Inc.	$176.74	31.89×	6.14×	5.96×	23.43×	-60.2%	52.4%	21.3%	18.8%	19.3%	12.6%	2.8%	0.5×	0.85×	13.21×	1.96×	0.7%	6	5.82	3	B+
AVTRAvantor, Inc.	$15.59	-14.69×	1.4×	1.19×	81.84×	23.5%	32.7%	-3.8%	-8.1%	-9.5%	-2.4%	6.4%	0.71×	25.82×	-1.45×	1.78×	0.0%	7	2.17	3	B+
BIOBio-Rad Laboratories, Inc.	$386.07	10.87×	1.11×	3.2×	7.65×	-146.4%	52.0%	10.5%	29.4%	10.2%	2.0%	4.5%	0.21×	0.83×	5.52×	5.62×	0.0%	7	3.65	3	B
MRVIMaravai LifeSciences Holdings, Inc.	$8.00	-3.57×	2.22×	2.54×	-4.86×	-66.3%	18.0%	-3.6%	-70.4%	-61.6%	-0.9%	-15.0%	0.17×	1.23×	-0.25×	6.6×	0.0%	4	4.88	1	C-
TECHBio-Techne Corporation	$72.78	60.38×	5.23×	9.07×	32.15×	-69.1%	65.8%	20.7%	15.0%	8.6%	7.5%	2.4%	0.14×	0.07×	46.6×	4.55×	0.5%	8	15.98	3	B
Peer median	—	10.87×	2.22×	3.2×	23.43×	-66.3%	52.0%	10.5%	15.0%	8.6%	2.0%	2.8%	0.21×	0.85×	5.52×	4.55×	0.0%	7	4.88	3	—